对NEK2抑制剂作为抗瘤剂的洞察:从机制到潜在的治疗方法
Yizhen Jiang1, Yutong Wang1, Feijing Su1
1Department of Respiratory and Critical Care Medicine, Targeted Tracer Research and Development Laboratory, Institute of Respiratory Healthand, Department of Frontiers Science Center for Disease-related Molecular Network, Core Facilities, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
European journal of medicinal chemistry
|January 20, 2025
概括
NEK2激酶对于细胞分裂至关重要,但其过度表达会导致癌症. 抑制NEK2对癌症治疗有希望,但开发有效的小分子抑制剂需要进一步的研究和创新.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- NEK2 (NIMA相关激酶2) 是一种氨酸/氨酸激酶,对线性过程至关重要.
- 在各种癌症中,NEK2的过度表达与中核细胞放大和染色体不稳定性有关.
- 这种过度表达有助于瘤的发展和治疗耐药性.
研究的目的:
- 审查NEK2.2的化学结构,生物功能和癌症相关性.
- 总结当前的小分子NEK2抑制剂,包括结构-活性关系和限制.
- 为开发新型NEK2抑制剂和克服临床翻译挑战提供见解.
主要方法:
- 对NEK2功能和抑制剂的文献综述.
- 对小分子抑制剂的结构-活性关系的分析.
- 讨论研究策略和临床翻译障碍.
主要成果:
- NEK2在细胞分裂中发挥着关键作用,其失调是致癌的.
- 已经开发了几种针对NEK2的小分子抑制剂,但没有一个达到临床试验.
- 当前抑制剂的局限性需要优化设计和创新的方法.
结论:
- 准NEK2是一种有前途的抗癌策略.
- 需要进一步的研究来开发临床可行的NEK2抑制剂.
- 克服药物设计和开发方面的挑战对于治疗成功至关重要.
相关概念视频
Electron Transport Chain: Complex I and II
10.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.8K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147


